共 6 条
[1]
温针灸对绝经后骨质疏松症患者骨密度及生化指标的影响[J] 赵利华;农泽宁;钟旋;庞勇;梁劲松;栗晓东;叶仿武; 中国针灸 2008, 12
[2]
Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre; double-blind; double-dummy; randomised controlled trial[J] David M Reid;Jean-Pierre Devogelaer;Kenneth Saag;Christian Roux;Chak-Sing Lau;Jean-Yves Reginster;Philemon Papanastasiou;Alberto Ferreira;Florian Hartl;Taiwo Fashola;Peter Mesenbrink;Philip N Sambrook The Lancet 2009,
[3]
Changes in bone markers after once-weekly low-dose alendronate in postmenopausal women with moderate bone loss[J] Hee-Jeong Choi;Jee-Aee Im;Sang-Hwan Kim Maturitas 2008,
[4]
Effect of dehydroepiandrosterone supplementation on bone mineral density; bone markers; and body composition in older adults: the DAWN trial[J] D. Mühlen;G. A. Laughlin;D. Kritz-Silverstein;J. Bergstrom;R. Bettencourt Osteoporosis International 2008,
[5]
A Double-Blind Placebo-Controlled Study of Intravenous Clodronate for Prevention of Steroid-Induced Bone Loss in Inflammatory Bowel Disease[J] Vered Abitbol;Karine Briot;Christian Roux;Carine Roy;Philippe Seksik;Antoine Charachon;Yoram Bouhnik;Benoit Coffin;Matthieu Allez;Dominique Lamarque;Stanislas Chaussade Clinical Gastroenterology and Hepatology 2007,
[6]
The effects of daily alendronate; daily calcitonin and alendronate every other day on bone mineral density in osteoporotic men[J] Zeynep Guven;Evrim Karadag-Saygi;Feyza Unlu-Ozkan;Gulseren Akyuz The Aging Male 2007,